Oramed Pharmaceuticals Stock Forecast
NASDAQ: ORMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ORMP analyst consensus
Consensus
none
Avg. price target
$7.00+60.18%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $7.00, with a high estimate of $7.00 and a low estimate of $7.00. The average target implies upside of 60.2% from the current price of $4.37. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ORMP.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $7.00 | +60.18% |
| Average target | $7.00 | +60.18% |
| High target | $7.00 | +60.18% |